info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players’ financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

ELISpot and FluoroSpot Assay Companies

Enzyme-Linked ImmunoSpot (ELISpot) and FluoroSpot assays are widely used in immunology research to detect and quantify the secretion of specific proteins, such as cytokines or antibodies, at the single-cell level. These assays are valuable tools for studying immune responses, vaccine development, and monitoring disease states. Companies involved in ELISpot and FluoroSpot assay technologies provide kits, reagents, instrumentation, and software to support researchers in their investigations.

ELISpot and FluoroSpot Assay Key Companies

 

Latest ELISpot and FluoroSpot Assay Companies Update

 


Mabtech (Sweden) Launched the Human IL-21 analyte in two colors in its FluoroSpot Flex platform, expanding its cytokine detection capabilities.Introduced ELISpot kits in a 100-plate format and pre-coated plates to save time and reduce assay variability.


Cellular Technology Limited (CTL) (US) Launched ImmunoSpot kits containing pre-coating quality controlled (PCQC) plates, adding an essential audit trail to ELISPOT analysis.Received ISO 13485 certification for its manufacturing facility, strengthening its commitment to quality standards.


Oxford Immunotec USA, Inc. (Subsidiary of Revvity Inc.) (UK) Expanded its global distribution network for its T-SPOT.TB test for the diagnosis of latent tuberculosis infection.Announced a collaboration with the Bill & Melinda Gates Foundation to improve access to its T-SPOT.TB test in low- and middle-income countries.


Abcam plc. (UK) Launched a series of new ELISpot kits for studying immune responses to COVID-19 vaccines and other infectious diseases.Partnered with academic institutions to develop and commercialize innovative ELISpot and FluoroSpot assay applications.


List of ELISpot and FluoroSpot Assay Key Companies in the Market



  • Oxford Immunotec (UK)

  • Cellular Technologies (US)

  • Mabtech (Sweden)

  • Becton

  • Dickinson and Company (US)

  • and Abcam (UK)Bio-Techne (US)

  • Autoimmun Diagnostika (Germany)

  • Biotech Investissement (France)

  • Lophius Biosciences (Germany)

  • U-CyTech (Netherlands)


Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.